Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Kyowa Pharma Expanding Focus Beyond Drugs, Eyes New Diagnostic/Treatment Options in CNS
July 17, 2020
- With New Chief at Helm, Mitsubishi Tanabe Looks to Boost Presence in Overseas Markets
July 16, 2020
- Medicago Begins PI Trial of COVID-19 Vaccine in Canada
July 16, 2020
- SanBio to Focus on Cell Therapy SB623 for Brain Injury, Stroke, Seeking Licensees for Other Indications
July 16, 2020
- Astellas to Transfer Antipsychotic Dogmatyl to Nichi-Iko
July 15, 2020
- Eisai Starts PIII Preclinical Alzheimer’s Study for BAN2401
July 15, 2020
- Shionogi, Ping An to Set Up JV in August, Make It a Hub for China/Asia Biz
July 14, 2020
- Nichi-Iko Execs Face Pay Cuts over Massive Recalls
July 14, 2020
- Keio Prof. Kenya Honda Becomes Scientific Advisor for 4BIO
July 14, 2020
- Tecentriq Fails to Improve PFS in Ovarian Cancer: Roche/Chugai
July 14, 2020
- Treakisym Filed for Triple Therapy in DLBCL
July 14, 2020
- 23 Drug Makers to Invest US$1 Billion in “AMR Action Fund” to Develop 2-4 New Antibiotics by 2030
July 14, 2020
- Takeda Looks to Derive 70%-Plus of Japan Sales from 5 Focus Areas by FY2025, Revamp HR Systems
July 13, 2020
- Eisai Joins Forces with Four Universities on R&D of Lupus Drug
July 13, 2020
- Bayer Revving Up Cell Therapy Drive with First Focus on Parkinson’s, Japan Biz Also Eyed: R&D Chief
July 10, 2020
- Yoshiaki Aono to Be Promoted to Chairman and President of Nippon BI in September
July 10, 2020
- Maruho’s Nemolizumab Hits Primary Goal in Japanese PIII for Itching in Atopic Dermatitis
July 10, 2020
- Xofluza Effective for Post-Exposure Prophylaxis of Influenza: Japan PIII
July 10, 2020
- Astex’s Inqovi Gets Approval in US, Canada: Otsuka
July 9, 2020
- Eisai Files Tazemetostat for Follicular Lymphoma in Japan
July 9, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…